Research Article | Open Access
Volume 2021 - 1 | Article ID 214 | http://dx.doi.org/10.51521/IRJCPT.2021.1302
Academic Editor: Pragathi Reddy
K. HARITHA PRIYA
*Pharm. D, Ratnam Institute of Pharmacy, Nellore, Andhra Pradesh, India
Corresponding Author: K.
Haritha Priya; *Pharm. D, Ratnam Institute of Pharmacy,
Nellore, Andhra Pradesh, India, 524346, Mob no: 8639251427
Citation: K. Haritha Priya (2021). Comparison of the Efficacy of Atorvastatin and Rosuvastatin in
Patients diagnosed as Coronary Artery Disease [CAD]: An Observational
Prospective Study. Int Res J Clin Stud Pharm Trends, 1(3); 1-3.
Copyright: © 2021, K. Haritha Priya
(2021). This is an open-access article distributed under the terms of the
Creative Commons Attribution 4.0 International License, which permits
unrestricted use, distribution and reproduction in any medium, provided the
original author and source are credited.
ABSTRACT:
Non-steroidal anti-inflammatory medication (NSAID)-induced Ischemic
colitis is an underappreciated but potentially deadly illness that results from
direct damage on the gut mucosa. Plain abdominal radiographs and multi-detector
computed tomography reveal right-sided acute colitis with associated
peri-colonic inflammation, progressively diminished changes along the
descending and sigmoid colon, and rectal sparing, all of which are consistent
with the NSAID colitis pathogenesis hypothesis. Through prevention and early
detection, increased knowledge of this disorder should minimize morbidity.
Consistent instrumental results, negative biochemistry, and stool studies,
together with high clinical suspicion and adequate patient questioning, can
assist clinicians avoid missing this critical diagnosis.
KEYWORDS: NSAID, Ischemic
Colitis, Peri-colonic inflammation, Early Detection.
.png)
.jpg)
.gif)
.jpg)
